Companies / United Kingdom
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
TB Vaccine Technology Transfer Announced
July 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
US-based Emergent Biosolutions has announced a joint venture with the University of Oxford for the development of a tuberculosis (TB) vaccine. The Oxford-Emergent Tuberculosis Consortium will have an exclusive licence to develop and commercialise TB vaccine candidate